| 28-Apr-2023 | D | In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. April 28, 2023, inter alia, has considered and unanimously:
Recommended equity dividend of Rs. 12 per share of Rs. 8/- each (150%) for the financial year ended March 31, 2023, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting. | 21-Jul-2023 | |
| 29-Apr-2022 | D | Recommended equity dividend of Rs. 9.60 per share of Rs. 8/- each (120%) for the financial year ended March 31, 2022, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting. | 14-Jul-2022 | |
| 30-Apr-2021 | D | Recommended equity dividend of Rs. 7.20 per share of Rs. 8/- each (90%) for the financial year ended March 31, 2021, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting | 13-Aug-2021 | |
| 18-Mar-2020 | D | The Board of Directors of the Company by way of passing the resolution by circulation on March 18, 2020 has declared an Interim Dividend of Rs.4/- per equity share of face value of Rs.8/- each fully paid up (50%), for the financial year 2019-20. | 24-Mar-2020 | |
| 29-Apr-2019 | D | In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has at its meeting held today i.e. April 29, 2019, inter alia, considered and approved the following:
Recommended an equity dividend of Rs. 2.40 per share of Rs. 8/- each (30%) for the financial year ended March 31, 2019, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting.
RPG Life Sciences Ltd has informed BSE that the Board of Directors of the Company has at its meeting held on April 29, 2019, inter alia, has considered and approved the following:
Recommended an equity dividend of Rs. 2.40 per share of Rs. 8/- each (30%) for the financial year ended March 31, 2019, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting.
(As Per BSE Announcement Dated 30.04.2019) | 22-Jul-2019 | |
| 02-May-2018 | D | RPG Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 02, 2018, inter alia, has recommended an equity dividend of Rs. 2.40/- per share of Rs. 8/- each (30%) for the financial year ended March 31, 2018, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting. | 19-Jul-2018 | |
| 28-Apr-2017 | D | This is to inform that the Board of Directors at its meeting held on April 28, 2017 has
recommended an equity dividend of Rs.2.80/- per share of Rs.8/- each (35%) for the year 2016-17 | 13-Jul-2017 | |
| 14-Mar-2016 | D | RPG Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 14, 2016 has recommended payment of Interim Dividend at the rate of Rs. 1.60 per Equity Share (20%) of Rs. 8/- each for the financial year 2015-16. Interim Dividend which shall be paid on or before March 30, 2016. | 22-Mar-2016 | |
| 29-Apr-2015 | D | RPG Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 29, 2015, inter alia, has recommended an equity dividend of Rs. 0.80 per share (10%) for the year ended March 31, 2015, subject to the approval of the shareholders at the ensuing Annual General Meeting. | 20-Jul-2015 | |
| 30-Apr-2014 | D | RPG Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 30, 2014, inter alia, has:
- recommended a normal dividend of Rs. 1.20 per share (15%) and a special dividend of Rs. 0.80 per share (10%) on account of extraordinary income aggregating to total dividend of Rs. 2.00 per share (25%) for the year ended March 31, 2014, subject to the approval of the members at the ensuing Annual General Meeting.
| 11-Sep-2014 | |
| 30-Apr-2014 | D | RPG Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 30, 2014, inter alia, has:
- recommended a normal dividend of Rs. 1.20 per share (15%) and a special dividend of Rs. 0.80 per share (10%) on account of extraordinary income aggregating to total dividend of Rs. 2.00 per share (25%) for the year ended March 31, 2014, subject to the approval of the members at the ensuing Annual General Meeting. | 11-Sep-2014 | |
| 07-May-2013 | D | RPG Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 07, 2013, inter alia, has approved the following:
1. Recommended an equity dividend of Rs.1.20 per share (15%) for the year ended March 31, 2013, subject to the approval of the members at the ensuing Annual General Meeting. | 11-Jul-2013 | |
| 27-Apr-2012 | D | RPG Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 27, 2012, inter alia, has recommended an equity dividend of Rs. 0.80 per share (10%) for the year ended March 31, 2012, subject to the approval of the members at the ensuing Annual General Meeting. | 24-Jul-2012 | |
| 28-Apr-2011 | D | RPG Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 28, 2011, inter alia, has recommended an equity dividend of Rs.1.60 per share (20%) for the year ended March 31, 2011, subject to the approval of the members at the ensuing Annual General Meeting. | 14-Jul-2011 | |
| 12-May-2010 | D | RPG Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2010, inter alia, recommended an equity dividend of Rs. 1.44 per share (18%) for the year ended March 31, 2010, subject to the approval of members. | 15-Jul-2010 | |
| 25-Jun-2009 | D | RPG Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 25, 2009, inter alia, has recommended an equity dividend of Rs 1.20 per share (15%) for the year ended March 31, 2009, subject to the approval of the members. | 30-Jul-2009 | |
| 30-Jun-2008 | D | RPG Life Sciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 30, 2008, inter alia, has recommended dividend @ 15% (Rs 1.20 per share) for the period ended on March 31, 2008. This will absorb Rs 2.02 crores including dividend distribution tax. | 11-Aug-2008 | |
| 01-Feb-2024 | BC | Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. | 01-May-2024 | |
| 23-Apr-2024 | BC | RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2024 inter alia to consider and approve Pursuant to the provisions of Regulation | 30-Apr-2024 | |
| 01-Feb-2024 | BC | In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the C | 07-Mar-2024 | |
| 25-Jan-2024 | BC | RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2024 inter alia to consider and approve Pursuant to the provisions of Regulation | 01-Feb-2024 | |
| 11-Oct-2023 | BC | RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/10/2023 inter alia to consider and approve Pursuant to the provisions of Regulation | 18-Oct-2023 | |